| Model Number |
NA-U200H-8019 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Fever (1858); Respiratory Tract Infection (2420)
|
| Date of Event |
03/25/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Olympus reviewed the following literature:disseminated tuberculosis following invasive procedures for peripancreatic lymph node tuberculosis with portal vein obstruction:a case report." literature summary: peripancreatic tuberculous lymphadenopathy can mimic pancreatic cancer on imaging.There have only a few reports on varices from portal vein obstruction due to abdominal tuberculous lymphadenopathy.Iatrogenic disseminated tuberculosis is also rare.Herein, we present a rare case of peripancreatic tuberculous lymphadenopathy with ruptured duodenal varices due to portal vein obstruction.The patient presented to our hospital with hematemesis.Computed tomography revealed a peripancreatic mass.Duodenal varices rupture from portal vein obstruction due to pancreatic cancer were initially suspected.The patient underwent portal vein stenting for portal vein obstruction and endoscopic ultrasound-guided fine-needle aspiration for diagnosis, which revealed granulomas indicative of tuberculosis.The patient was discharged once because fine-needle aspiration did not lead to a definitive diagnosis of tuberculosis.Subsequently, he developed disseminated tuberculosis.Peripancreatic tuberculous lymphadenopathy can cause ectopic varices with portal vein obstruction.Tuberculosis should also be included in the differential diagnosis in the case of portal vein obstruction, to facilitate early treatment and avoid unnecessary surgery.Furthermore, fine-needle aspiration or portal vein stenting for tuberculous lesions can cause disseminated tuberculosis.Since a diagnosis might not be made until after several fine-needle aspirations have been conducted, careful follow-up is necessary after the procedure for such lesions.Type of adverse events/number of patients fever of 40 °c positive for m.Tuberculosis since the literature described "19g/22g ez-shot 3 plus", we selected "na-u200h-8019" as a representative product.
|
| |
|
Additional Manufacturer Narrative
|
|
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
| |
|
Additional Manufacturer Narrative
|
|
This supplemental report is being submitted to provide additional information from the author, the legal manufacturer's investigation.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.No malfunctions were reported.Olympus will continue to monitor field performance for this device.
|
| |
|
Event or Problem Description
|
|
The author responded to our request for additional information and he reported the olympus devices did not cause or contribute to the reported events.The devices did not malfunction.
|
| |
|
Search Alerts/Recalls
|